” Pharmaceutical firms currently pay about £40m every year to healthcare professionals, including doctors and pharmacists. These payments could be for anything from expert advice to sponsoring a healthcare professional’s medical education. Now, the Association of the British Pharmaceutical Industry (ABPI) has created a central database, going live in June, on which its member companies, and others that have signed up to comply with the ABPI code of practice, will disclose who these payments are made to, and for what. At the same time, Jeremy Hunt’s “sunshine rule” will make it mandatory for NHS staff to declare gifts received from drug companies.
Read: How much should patients know about pharma payments to doctors?, the guardian, 18 May 2016.
How will this new transparency affect the complex matrix of relationships between health professionals, pharmaceutical firms, the NHS and, most importantly, patients? “